George M. Savage
Gründer bei Proteus Digital Health, Inc.
Aktive Positionen von George M. Savage
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Proteus Digital Health, Inc.
Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Proteus Digital Health, Inc. develops medicine products and therapeutic devices. It provides digital health products that collect behavioral, physiologic, and therapeutic metrics, such as medication adherence, heart rate, sleep patterns, physical activity, and stress levels into personal management tools delivered to the mobile devices of consumers. The company was founded by Andrew M. Thompson, George M. Savage, and Mark J. Zdeblick in 2001 and is headquartered in Redwood City, CA. | Technik-/Wissenschafts-/F&E-Leiter | 02.09.2009 | - |
Gründer | 01.01.2001 | - | |
Corporate Officer/Principal | 01.07.2001 | 02.09.2009 |
Karriereverlauf von George M. Savage
Ehemalige bekannte Positionen von George M. Savage
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Spring Ridge Ventures
Spring Ridge Ventures Investment ManagersFinance Spring Ridge Ventures (Spring Ridge Ventures) is a venture capital firm founded in 2000 by George M. Savage and Andrew Thompson. The firm is headquartered in Menlo Park, California. | Chief Investment Officer | 01.01.2000 | 31.01.2021 |
Gründer | 17.11.2010 | 31.01.2021 | |
Private Equity Investor | 17.11.2010 | 31.01.2021 | |
FemRx, Inc.
FemRx, Inc. Medical SpecialtiesHealth Technology Part of Johnson & Johnson, FemRx, Inc. is a company that produces medical products for gynecological disorders. The company is based in Sunnyvale, CA. FemRx was acquired by Johnson & Johnson on November 06, 1998 for $20.99 million. | Corporate Officer/Principal | - | - |
CardioRhythm
CardioRhythm Medical SpecialtiesHealth Technology Part of Medtronic Plc, CardioRhythm is a company that manufactures electrophysiological catheters. The company is based in San Jose, CA. CardioRhythm was acquired by Medtronic, Inc., part of Medtronic Plc from January 27, 2015 on May 26, 1992. | Corporate Officer/Principal | - | - |
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer. | Corporate Officer/Principal | - | - |
Ausbildung von George M. Savage
Boston University | Undergraduate Degree |
Stanford University | Masters Business Admin |
Tufts University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Operativ
Corporate Officer/Principal | 4 |
Founder | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 4 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Proteus Digital Health, Inc.
Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Proteus Digital Health, Inc. develops medicine products and therapeutic devices. It provides digital health products that collect behavioral, physiologic, and therapeutic metrics, such as medication adherence, heart rate, sleep patterns, physical activity, and stress levels into personal management tools delivered to the mobile devices of consumers. The company was founded by Andrew M. Thompson, George M. Savage, and Mark J. Zdeblick in 2001 and is headquartered in Redwood City, CA. | Health Technology |
Spring Ridge Ventures
Spring Ridge Ventures Investment ManagersFinance Spring Ridge Ventures (Spring Ridge Ventures) is a venture capital firm founded in 2000 by George M. Savage and Andrew Thompson. The firm is headquartered in Menlo Park, California. | Finance |
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer. | Health Technology |
CardioRhythm
CardioRhythm Medical SpecialtiesHealth Technology Part of Medtronic Plc, CardioRhythm is a company that manufactures electrophysiological catheters. The company is based in San Jose, CA. CardioRhythm was acquired by Medtronic, Inc., part of Medtronic Plc from January 27, 2015 on May 26, 1992. | Health Technology |
FemRx, Inc.
FemRx, Inc. Medical SpecialtiesHealth Technology Part of Johnson & Johnson, FemRx, Inc. is a company that produces medical products for gynecological disorders. The company is based in Sunnyvale, CA. FemRx was acquired by Johnson & Johnson on November 06, 1998 for $20.99 million. | Health Technology |
- Börse
- Insiders
- George M. Savage
- Erfahrung